• Asian Pacific Journal of Cancer Prevention
• /
• 제17권3호
• /
• pp.1023-1035
• /
• 2016

The purpose of this study was to investigate the role of colon cancer stem cells (CSCs) during chemically-induced rat multi-step colon carcinogenesis with or without the treatment with a specific cyclooxygenase-2 inhibitor drug (celecoxib). Two experiments were performed, the first, a short term 12 week colon carcinogenesis bioassay in which only surrogate markers for colon cancer, aberrant crypt foci (ACF) lesions, were formed. The other experiment was a medium term colon cancer rat assay in which tumors had developed after 32 weeks. Treatment with celecoxib lowered the numbers of ACF, as well as the tumor volumes and multiplicities after 32 weeks. Immunohistochemical proliferating cell nuclear antigen (PCNA) labeling indexes LI (%) were downregulated after treatment by celecoxib. Also different cell surface antigens known to associate with CSCs such as the epithelial cell adhesion molecule (EpCAM), CD44 and CD133 were compared between the two experiments and showed differential expression patterns depending on the stage of carcinogenesis and treatment with celecoxib. Flow cytometric analysis demonstrated that the numbers of CD133 cells were increased in the colonic epithelium after 12 weeks while those of CD44 but not CD133 cells were increased after 32 weeks. Moreover, aldehyde dehydrogenase-1 activity levels in the colonic epithelium (a known CSC marker) detected by ELISA assay were found down-regulated after 12 weeks, but were up-regulated after 32 weeks. The data have also shown that the protective effect of celecoxib on these specific markers and populations of CSCs and on other molecular processes such as apoptosis targeted by this drug may vary depending on the genetic and phenotypic stages of carcinogenesis. Therefore, uncovering these distinction roles of CSCs during different phases of carcinogenesis and during specific treatment could be useful for targeted therapy.

• Parasites, Hosts and Diseases
• /
• 제32권1호
• /
• pp.13-18
• /
• 1994

간흡충은 담관내에 기생하면서 만성적 감염의 결과 최종적으로 담관암을 유발시키는 것으로 알려져 왔다. 실험동물에서 간흡충의 감염만으로는 담관암이 발생하지 않으며, 어떠한 외적 혹은 내적 발암성의 물질들과 병합하여 담관암이 형성하는 것으로 보고된 바 있다 본 실험은 햄스터에서 간흡충의 감염과 dimethylnitrosamine(DMN)의 병합작용으로 담관암이 발생되었다는 모델을 이용하여 "발암기전의 2단계이론" 상에서 간흡충의 역할을 밝혀보고자 하였다. 총 90마리의 햄스터를 15 마리씩 6군으로 나누었다. $DMN{\;}{\rightarrow}{\;}CS$군의 햄스터에서는 먼저 15 ppm의 DMN을 4주 동안 음수 투여하고, 1주 후에 간흡충을 15마리씩 인공감염시켰다. 그리고 5주 후에 piaziquantel로 간흡충을 치료하였다 $CS{\;}{\rightarrow}{\;}DMN$군에서는 먼저 간홉충을 감염시키고 5주 후에 praziquantel로 치료하였으며 1주 후부터 DMN을 4주동안 투여하였다. DMN + CS군에서는 DMN과 간흠충을 동시에 투여하였으며 4주 후에는 DMN을 제거하였다. DMN군과 CS군은 각각 DMN과 간흡충만을 투여하였고 대조군은 아무것도 투여하지 않았다. 모든 실험동물은 13주 후에 부검하였으며 조직병리학적인 방법으로 간장을 검경하여 진단하였다. 실험결과 담관암은 $DMN{\;}{\rightarrow}{\;}CS$군에서 3마리, DMN + CS군에서 11마리가 발생하였으며 나머지 군들에서는 암이 발생하지 않았다. 본 실험으로 2단계 발암기 전상에서 간흡충은 담관암발생을 촉진하는 효과를 보였음을 알수 있었다.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제19권4호
• /
• pp.414-434
• /
• 1997

Though many genetic and epigenetic alterations have been identified in hamster oral carcinogenesis model, there is no information about the possible role of transforming growth factor related with oral cancer. The purpose of this paper was to find the expression patterns of transforming growth factor alpha and beta during the stages of complete oral carcinogenesis model in hamster. 0.5% 9, 10-dimethyl-1, 2-benzanthracene(DMBA) in mineral oil was topically applied to the buccal pouch of 75 hamster three times a week during the experimental periods. The experimental animals were subdivided into two groups of control and experiment. Only the mineral oil was applied to the control group. 0.5% DMBA in mineral oil was applied to the experimental groups of 6, 8, 10, 12, 14, 16, 18 and 20 weeks. The expression of the $TGF-{\alpha}$ and $TGF-{\beta}$ protein were evaluated by the distribution and intensity of positive cells during the carcinogenesis using the immunohistochemical study. The following results were obtained ; 1. The buccal pouch epithelium of hamster was histologically changed to the dysplasia at 6, 8, 10 weeks, carcinoma in situ at 12 weeks, and squamous cell carcinoma at 14 weeks. 2. The expression of the $TGF-{\alpha}$ was restricted to the parabasal and basal layers of the normal and dysplastic mucosa, but those positive cells were extended to the spinous layers of the epithelium in the carcinoma. 3. The degree of $TGF-{\alpha}$ expression was markedly decreased in the carcinoma at 16, 18, 20. The strong positive staining in the center of cancer islands and weak positive staining in periphery of tumor were seen at the stage of squamous cell carcinoma. 4. The positive index of the $TGF-{\alpha}$ had a tendency to increase with DMBA- applied time. There was a statistically significant difference between 12, 18, 20 experimental group and control group (p<0.05). 5. The expression of the $TGF-{\beta}$ was shown at the cytoplasm of all control and experimental groups, and the parabasal and basal layers of the normal and dyslastic mucosa, but it was shown at the basal layers of the epithelium in the carcinoma. 6. $TGF-{\beta}$ was expressed diffusely at 16, 18, 20 experimental group. The strong positive staining in the center of cancer islands and positive staining in periphery of tumor were seen at the stage of squamous cell carcinoma. From the above findings, the expression of $TGF-{\alpha}$ and ${\beta}$ in oral carcinogenesis model seems to have two formal stages, the first being an overexpression step as reaction to uncontrolled growth and the second being one in which external protein accumulate in the surrounding stroma and intracytoplasm. Overexpression of $TGF-{\alpha}$ and ${\beta}$ may have important cooperative roles for the promotion of cancer and factor of prognosis.

• 대한화학회지
• /
• 제24권3호
• /
• pp.225-232
• /
• 1980

化學發癌物質인 縮合炭化水素, 헤테로고리化合物 그리고 디메틸아미노아조벤젠 및 그의 유도체들의 電子狀態를 HMO로 調査하고 그들의 發癌活性을 論議하였다. K-領域의 두 原子와 그의 이웃한 L-領域의 原子들의 親核反應의 프론티어 전자밀도의 合의 값이 0.5 以上인 化合物들은 發癌活性에 있어서 實驗結果와 一致함을 알았다. 따라서 K-領域과 L-領域이 發癌作用의 첫단계로서 化學發癌物質과 生體成分과의 結合이 얻어진다는 것이 보고되어 있는 分子錯物의 形成에 重要한 役割을 한다고 생각한다.

• Journal of Preventive Medicine and Public Health
• /
• 제28권1호
• /
• pp.141-152
• /
• 1995

This study was performed to find out the influences of ethanol on the metabolism of trichloroethylene(TRI) in rats. TRI in corn oil at the dosage of 150, 300, 600 mg/kg was injected peritoneally once a day for two days to two groups. In one group ethanol(4 g/kg) was taken orally 30 minutes before TRI injection, and the other group ethanol was not. The results of experiments are as follows: 1. The contents of cytochrome P-450 and $b_5$ had inverse relationship with in-jected TRI amounts in both groups. 2. The activity of NADPH P-450 reductase was decreased slowly in TRI injected group related with TRI amount, but decreased drastically in the group pretreated with ethanol. 3. The activity of NADH $b_5$ reductase had relationship with injected nt amount , but the statistical significance was found only in the groups of 300 and 600 mg/kg of TRI injected without relevance to ethanol when compared with the group that was not injected. 4. The activity of ADH was more decreased and ALDH activity was more increased in groups that TRI injected and ethanol was pretreated with ethanol groups than in group without any treatment. These results suggest that ethanol may inhibit epoxide formulation, the first step of TRI metabolism, and change from TCE-OH to TCA also.

• 대한화학회지
• /
• 제24권4호
• /
• pp.280-287
• /
• 1980

發癌物質과 DNA 鹽基雙間의 分子錯物形成에서 可能性있는 配置(orientation)를 決定하였다. 아데닌-티민 염기쌍에서는 티민쪽에서, 구아닌-시토신 염기쌍에서는 구아닌쪽에서 分子錯物을 形成한다.

• International journal of thyroidology
• /
• 제11권2호
• /
• pp.123-129
• /
• 2018

Background and Objectives: Hypermethylation of the tumor suppressor gene RASSF1A and activating mutation of BRAF gene have been recently reported in thyroid cancers. To investigate the role of these two epigenetic and genetic alterations in thyroid tumor progression, methylation of RASSF1A and BRAF mutation were examined in thyroid tumors. Materials and Methods: During 2007 to 2017, 69 papillary carcinomas, 18 nodular hyperplasia, 3 follicular carcinomas, and 13 follicular adenomas were selected. The methylation-specific polymerase chain reaction (MSP) technique was used in detecting RASSF1A methylation and polymerase chain reaction (PCR)-single-stranded conformation polymorphism and sequencing were used for BRAF gene mutation study. Results: The hypermethylation of the RASSF1A gene was found in 84.6%, 100% and 57.9% of follicular adenomas, follicular carcinomas, and papillary carcinomas, respectively. Nodular hyperplasia showed a hypermethylation in 33.3%. The BRAF mutation at V600E was found in 60.7% of papillary carcinoma and 27.0% of nodular hyperplasia, but none of follicular neoplasms. The BRAF mutation was correlated with the lymph node metastasis and MACIS clinical stage. There is an inverse correlation between RASSF1A methylation and BRAF mutation in thyroid lesions. Conclusion: Epigenetic inactivation of RASSF1A through aberrant methylation is considered to be an early step in thyroid tumorigenesis, and the BRAF mutation plays an important role in the carcinogenesis of papillary carcinoma, providing a genetic marker.

• Tuberculosis and Respiratory Diseases
• /
• 제44권6호
• /
• pp.1285-1295
• /
• 1997

연구배경 : 종양형성다단계 과정중의 하나인 EGFR(epidermal growth factor receptor)은 170KDa의 당단백질로서 세포막의 안팎에 걸친 수용체로서 EGF, TGF alph 의 자극에 의해서 신호전달체계의 시작을 담당한다. EGFR은 정상세포에도 존재가능하나 종양에서는 발현이 증가되어 있으며, EGFR의 발현이 높을수록 종양의 예후가 불량하리라 예측된다. 이에 저자들은 비소세포 폐암에서 EGFR의 발현을 확인하고 EGFR의 임상적 의의 특히 생존률과의 관계를 검색 하였다. 방 법 : 원발성 비소세포 폐암으로 확진받고, 외과적 절제술후 paraffin에 보관된 57례의 병리조직에서 면역 조직화학법으로 EGFR의 발현을 확인하고, EGFR과 암세포형, TNM 병기, 세포분화도, 유식세포 분석법에 의한 S 및 $G_1$ 주기비율 그리고 생존 기간과의 관계를 분석하였다. 결 과 : 1) 57례중 남녀비는 43 : 14였고, 중간 연령은 62세였다. EGFR과 생존기간과의 경향을 파악하기 위해, 종양세포중 EGFR 양성 세포가 20% 이상인 경우만을 발현군으로 하였을 때 56%에서 발현되었다. 2) EGFR의 발현은 병리조직형에 따른 차이는 없었고, TNM병기 그리고 세포의 분화도에 따른 차이도 없었다. 3) EGFR 발현군과 비발현군에서의 S-주기비율은 22.3(${\pm}10.5$)%, 18.0(${\pm}10.9$)% 였고, $G_1$-주기비율은 68.4(${\pm}11.6$)%, 71.1(${\pm}12.8$)%로서 모두 양군간의 유의한 차이는 없었다. 4) EGFR 발현군과 비발현군에서의 1년 생존률은 66%, 96%, 2년 생존률은 53%, 84%, 3년 생존률은 38%, 66%였고 중간 생존기간은 26개월, 53개월로서 유의한 차이가 있었다. 결 론 : 비소세포 폐암에서 EGFR은 56%에서 발현되었으며, 조직병리형, TNM 병기, 세포분화도에 따른 발현의 차이는 없었다. 발현군과 비발현군에서의 S 및 $G_1$ 주기비율은 차이가 없었다. EGFR 발현군과 비발현군의 2년 생존률은 53%, 84%였으며, 중간 생존기간은 26개월, 53개월이었다 (p<0.05). 즉 결과적으로 EGFR 발현이 높을수록 생존기간은 불량하여 예후추정인자로서의 이용이 가능하리라 판단된다.